Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic
Santiago Ortega‐Gutiérrez, Mudassir Farooqui, Alicia Zha, Alexandra L. Czap, Jacob Sebaugh, Shashvat Desai, Ashutosh P. Jadhav, Nirav Vora, Vivek Rai, Tudor G. Jovin, Jesse Thon, Mark Heslin, Lauren Thau, Cynthia Zevallos, Darko Quispe‐Orozco, Dinesh Jillella, Fadi Nahab, Mahmoud Mohammaden, Raul G. Nogueira, Diogo C Haussen, Thanh N. Nguyen, José R. Romero, Hugo J. Aparicio, Mohamed Osman, Israr Ul Haq, David S. Liebeskind, Ameer E Hassan, Osama O. Zaidat, James E. Siegler
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)ThrombolysisPandemic2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Stroke (engine)BetacoronavirusEmergency medicineAnesthesiaIntensive care medicineVirologyCardiologyInternal medicineMyocardial infarctionDiseaseInfectious disease (medical specialty)OutbreakEngineeringMechanical engineeringLong-Term Effects of COVID-19COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies